Evaluating the Effectiveness of Decitabine With Gemcitabine, Oxaliplatin for Relapsed/Refractory Peripheral T-cell Lymphoma
Clinical trial NCT06941688 · TERMINATED
Trial details
- NCT number
- NCT06941688
- Sponsor
- Seoul National University Hospital
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-13
- Primary completion
- 2024-08-13
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.